D. Boral Capital Maintains Buy on Coya Therapeutics, Maintains $15 Price Target

Benzinga · 01/05 13:33
D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $15 price target.